Article Text
Abstract
The aim of our survey was to capture the attitudes of Swedes to marginal donors and xenotransplantation. Modern biotechnology makes it possible to replace non-functioning organs, cells, and genes. Nonetheless, people may have reservations and fears about such treatments. With the survey, Attitudes of the General Public to Transplants, we have sought to expose the ambivalence that arises when medical possibilities are juxtaposed with ideas of risk. The design of the questionnaire originates from the interdisciplinary cooperation between ethnologists, medical scientists, and geneticists. By combining qualitative and quantitative methods, it is possible to illustrate the complexity that characterises people’s view of modern biomedicine. People’s reflections are based on a personal and situation bound morality, which does not necessarily coincide with what they generally consider as ethically justifiable.
- marginal donors
- xenotransplantation
- culture
- ethics
- risk
- interdisciplinary research
Statistics from Altmetric.com
Footnotes
-
↵* Questions 1–7 are taken from the survey.
Other content recommended for you
- Starting clinical trials of xenotransplantation—reflections on the ethics of the early phase
- The donor lung: conservation of a precious resource
- Objective assessment of criteria for selection of donor lungs suitable for transplantation
- Genetic disenhancement and xenotransplantation: diminishing pigs’ capacity to experience suffering through genetic engineering
- Does it matter that organ donors are not dead? Ethical and policy implications
- Xenotransplantation: a bioethical evaluation
- Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
- PreImplantation Trial of Histopathology In renal Allografts (PITHIA): a stepped-wedge cluster randomised controlled trial protocol
- “One man’s trash is another man’s treasure”: exploring economic and moral subtexts of the “organ shortage” problem in public views on organ donation
- Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial